| 460 |
increased |
atrophy
(MESH:D001284)
|
olfactory epithelium
(UBERON:0001997)
|
868: Increase, Tissue Degeneration, Necrosis & Atrophy
|
| 459 |
increased |
leukocyte mediated cytotoxicity
(GO:0001909)
|
|
768: Increase, Cytotoxicity
|
| 458 |
decreased |
regulation of intracellular pH
(GO:0051453)
|
|
867: Decrease, Intracellular pH
|
| 457 |
increased |
|
uroporphyrinogen
(CHEBI:27258)
|
844: Oxidation, Uroporphyrinogen
|
| 456 |
increased |
porphyria
(MP:0005654)
|
|
369: Uroporphyria
|
| 455 |
decreased |
catalytic activity
(GO:0003824)
|
uroporphyrinogen decarboxylase
(PR:000017134)
|
845: Inhibition, UROD
|
| 454 |
increased |
gene expression
(GO:0010467)
|
cytochrome P450 1A5 (chicken)
(PR:P79761)
|
850: Induction, CYP1A2/CYP1A5
|
| 453 |
increased |
gene expression
(GO:0010467)
|
cytochrome P450 1A2
(PR:000006102)
|
850: Induction, CYP1A2/CYP1A5
|
| 452 |
increased |
|
porphyrins
(CHEBI:26214)
|
846: Accumulation, Highly carboxylated porphyrins
|
| 451 |
functional change |
|
lysosome
(GO:0005764)
|
831: Disturbance, Lysosomal function
|
| 450 |
occurrence |
autophagic cell death
(GO:0048102)
|
|
4 Events
|
| 449 |
decreased |
phospholipase activity
(GO:0004620)
|
phospholipase A1 member A (human)
(PR:Q53H76)
|
828: Inhibition, Phospholipase A
|
| 448 |
increased |
Microvesicular hepatic steatosis
(HP:0001414)
|
|
838: Induction, Microvesicular fat
|
| 447 |
occurrence |
Mallory bodies
(MP:0014045)
|
|
839: Formation, Mallory body
|
| 446 |
functional change |
|
Lipid bilayer of wall of lysosome
(FMA:67514)
|
829: Damage, Lipid bilayer
|
| 445 |
occurrence |
podocyte vacuolization
(MP:0011899)
|
|
824: Occurrence, Cytoplasmic vacuolization (podocyte)
|
| 444 |
occurrence |
Dilatation
(MESH:D004106)
|
renal tubule
(UBERON:0009773)
|
823: Occurrence, Cystic dilatation (renal tubule)
|
| 443 |
occurrence |
autophagic cell death
(GO:0048102)
|
renal tubule
(UBERON:0009773)
|
818: Occurrence, Cytoplasmic vacuolization (Renal tubule)
|
| 442 |
occurrence |
toxicity
(MESH:Q000633)
|
kidney
(UBERON:0002113)
|
814: Occurrence, Kidney toxicity
|
| 441 |
increased |
abnormal amino acid level
(MP:0005332)
|
|
813: Increased, Serum creatinine
|
| 440 |
increased |
|
creatinine
(CHEBI:16737)
|
813: Increased, Serum creatinine
|
| 439 |
decreased |
function
(MI:0613)
|
kidney
(UBERON:0002113)
|
825: Decreased, Renal ability to dilute urine
|
| 438 |
decreased |
renal absorption
(GO:0070293)
|
sodium(1+)
(CHEBI:29101)
|
821: Decreased, Sodium reabsorption
|
| 437 |
decreased |
kidney plasma flow trait
(VT:0005524)
|
|
820: Decreased, Renal plasma flow
|
| 436 |
decreased |
glomerular filtration
(GO:0003094)
|
|
819: Decreased, Glomerular filtration
|